Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter PD-L1 Antikörper (AA 39-191)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch PD-L1 in WB und IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7126487

Kurzübersicht für Rekombinanter PD-L1 Antikörper (AA 39-191) (ABIN7126487)

Target

Alle PD-L1 Antikörper anzeigen
PD-L1 (CD274 (PD-L1))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 276
  • 144
  • 72
  • 6
  • 6
  • 5
  • 5
  • 1
  • 1
Human

Wirt

  • 156
  • 145
  • 22
  • 5
  • 4
  • 4
  • 2
  • 1
Maus

Klonalität

  • 208
  • 122
  • 7
Monoklonal

Konjugat

  • 158
  • 28
  • 14
  • 12
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser PD-L1 Antikörper ist unkonjugiert

Applikation

  • 194
  • 148
  • 96
  • 74
  • 46
  • 45
  • 44
  • 40
  • 28
  • 15
  • 11
  • 10
  • 7
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 71
    • 29
    • 16
    • 15
    • 14
    • 11
    • 11
    • 10
    • 7
    • 7
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 39-191

    Spezifität

    PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 39-191) of human CD274 (PD-L1) protein (exact sequence is proprietary)

    Isotyp

    IgG2a
  • Applikationshinweise

    Known_Application: Western Blot (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: NIH3T3, PC3 or MCF-7 cells. Human placenta, spleen or tonsil tissue.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    PD-L1 (CD274 (PD-L1))

    Andere Bezeichnung

    CD274

    Hintergrund

    B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1,PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)
    Cellular localisation: Cell Surface and Cytoplasmic

    Molekulargewicht

    37-50kDa

    Gen-ID

    29126, 521989

    UniProt

    Q9NZQ7

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!